Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $2.10 and last traded at $2.18, with a volume of 3239421 shares traded. The stock had previously closed at $3.12.
Wall Street Analyst Weigh In
Several analysts have issued reports on CURLF shares. Needham & Company LLC restated a “buy” rating and issued a $6.25 price objective on shares of Curaleaf in a research note on Thursday, August 8th. Cormark upgraded Curaleaf from a “hold” rating to a “moderate buy” rating in a research note on Monday, August 12th.
Read Our Latest Stock Analysis on CURLF
Curaleaf Trading Down 30.3 %
Curaleaf (OTCMKTS:CURLF – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.01). Curaleaf had a negative return on equity of 14.75% and a negative net margin of 18.59%. The company had revenue of $342.29 million for the quarter, compared to analyst estimates of $344.57 million. On average, equities analysts anticipate that Curaleaf Holdings, Inc. will post -0.24 EPS for the current fiscal year.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
- Five stocks we like better than Curaleaf
- What is the Nikkei 225 index?
- What a Trump Win Looks Like for the Market Now and Into 2025
- The Role Economic Reports Play in a Successful Investment Strategy
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.